A clinical trial evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke. Researchers found that taking ticagrelor in addition to aspirin reduced the risk of a composite of cardiovascular death, heart attack, or stroke.
Source: Care Giving Science Daily